Literature DB >> 10853172

Complications of irradiated allografts in orthopaedic tumor surgery.

S A Lietman1, W W Tomford, M C Gebhardt, D S Springfield, H J Mankin.   

Abstract

Massive structural allografts used for replacement of bone defects after removal of bone tumors have several complications, including fracture, infection, and nonunion. To decrease the rate of infection, irradiation of selected allografts before their implantation was performed. This study evaluated the complications in patients with these irradiated grafts. Twenty-four patients were identified who had received allografts from 1987 through 1991 that were irradiated before implantation. The dosage of radiation was between 10 kGy and 30 kGy. The mean length of followup of the patients was 5 years (range, 2-9 years). These grafts were compared with a control group of grafts that were not irradiated but were implanted during the same time and used for similar diagnostic problems with defects of similar size. The outcomes of the groups differed significantly only in the incidence of allograft fracture. These findings indicate that high-dose irradiation to bone allografts is associated with a higher rate of fracture than are similar reconstructions using nonirradiated allografts.

Entities:  

Mesh:

Year:  2000        PMID: 10853172     DOI: 10.1097/00003086-200006000-00026

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  Gamma Radiation Sterilization Reduces the High-cycle Fatigue Life of Allograft Bone.

Authors:  Anowarul Islam; Katherine Chapin; Emily Moore; Joel Ford; Clare Rimnac; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2015-10-13       Impact factor: 4.176

2.  Effects of ex vivo ionizing radiation on collagen structure and whole-bone mechanical properties of mouse vertebrae.

Authors:  Megan M Pendleton; Shannon R Emerzian; Jennifer Liu; Simon Y Tang; Grace D O'Connell; Joshua S Alwood; Tony M Keaveny
Journal:  Bone       Date:  2019-08-21       Impact factor: 4.398

3.  Extracorporeally irradiated autografts for the treatment of bone tumours: tips and tricks.

Authors:  Bart Poffyn; Gwen Sys; Alexander Mulliez; Georges Van Maele; Luc Van Hoorebeke; Ramses Forsyth; Dirk Uyttendaele
Journal:  Int Orthop       Date:  2010-07-22       Impact factor: 3.075

4.  Survival of massive allografts in segmental oncological bone defect reconstructions.

Authors:  P H J Bullens; N M Minderhoud; M C de Waal Malefijt; R P H Veth; P Buma; H W B Schreuder
Journal:  Int Orthop       Date:  2008-12-03       Impact factor: 3.075

5.  Structural bone allograft fractures in oncological procedures.

Authors:  Javier Garcia-Coiradas; Roberto Garcia-Maroto; Juan Luis Cebrian; Luis Lopez-Duran
Journal:  Int Orthop       Date:  2015-09-03       Impact factor: 3.075

6.  Functional outcome following excision of a tumour and reconstruction of the distal radius.

Authors:  Apichat Asavamongkolkul; Saranatra Waikakul; Rapin Phimolsarnti; Piya Kiatisevi
Journal:  Int Orthop       Date:  2007-08-28       Impact factor: 3.075

7.  Radioprotectant and radiosensitizer effects on sterility of gamma-irradiated bone.

Authors:  Seema A Kattaya; Ozan Akkus; James Slama
Journal:  Clin Orthop Relat Res       Date:  2008-05-17       Impact factor: 4.176

8.  Results of 32 allograft-prosthesis composite reconstructions of the proximal femur.

Authors:  David J Biau; Frédérique Larousserie; Fabrice Thévenin; Sophie Piperno-Neumann; Philippe Anract
Journal:  Clin Orthop Relat Res       Date:  2009-10-23       Impact factor: 4.176

9.  Bisphosphonate delivery to tubular bone allografts.

Authors:  Gene R DiResta; Mark W Manoso; Anwar Naqvi; Pat Zanzonico; Peter Smith-Jones; Wakenda Tyler; Carol Morris; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2008-04-26       Impact factor: 4.176

10.  Radioprotection of tendon tissue via crosslinking and free radical scavenging.

Authors:  Aaron Seto; Charles J Gatt; Michael G Dunn
Journal:  Clin Orthop Relat Res       Date:  2008-05-30       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.